Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Abstract Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis of eight million reports from the FDA Advers...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Isaac V. Cohen, Tigran Makunts, Rabia Atayee, Ruben Abagyan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/29cfb95bdea44b70a57ebcd61bd9f670
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!